Researchers at U of T Engineering have developed a new way of growing realistic human tissues outside the body. Their “person-on-a-chip” technology, called AngioChip, is a powerful platform for discovering and testing new drugs, and could eventually be used to repair or replace damaged organs.
Professor Milica Radisic (IBBME, ChemE), graduate student Boyang Zhang and their collaborators are among those research groups around the world racing to find ways to grow human tissues in the lab, under conditions that mimic a real person’s body. They have developed unique methods for manufacturing small, intricate scaffolds for individual cells to grow on. These artificial environments produce cells and tissues that resemble the real thing more closely than those grown lying flat in a petri dish.
he team’s recent creations have included BiowireTM — an innovative method of growing heart cells around a silk suture — as well as a scaffold for heart cells that snaps together like sheets of Velcro™. But AngioChip takes tissue engineering to a whole new level. “It’s a fully three-dimensional structure complete with internal blood vessels,” says Radisic. “It behaves just like vasculature, and around it there is a lattice for other cells to attach and grow.” The work — which is published todayin the journal Nature Materials — was produced collaboratively with researchers from across U of T, including Professor Michael Sefton (ChemE, IBBME), Professor Aaron Wheeler (Chemistry, IBBME) and their research teams, as well as researchers from Toronto General Hospital and University Health Network.
Zhang built the scaffold out of POMaC, a polymer that is both biodegradable and biocompatible. The scaffold is built out of a series of thin layers, stamped with a pattern of channels that are each about 50 to 100 micrometres wide. The layers, which resemble the computer microchips, are then stacked into a 3D structure of synthetic blood vessels. As each layer is added, UV light is used to cross-link the polymer and bond it to the layer below.
When the structure is finished, it is bathed in a liquid containing living cells. The cells quickly attach to the inside and outside of the channels and begin growing just as they would in the human body.
“Previously, people could only do this using devices that squish the cells between sheets of silicone and glass,” says Radisic. “You needed several pumps and vacuum lines to run just one chip. Our system runs in a normal cell culture dish, and there are no pumps; we use pressure heads to perfuse media through the vasculature. The wells are open, so you can easily access the tissue.”
Using the platform, the team has built model versions of both heart and liver tissues that function like the real thing. “Our liver actually produced urea and metabolized drugs,” says Radisic. They can connect the blood vessels of the two artificial organs, thereby modelling not just the organs themselves, but the interactions between them. They’ve even injected white blood cells into the vessels and watched as they squeezed through gaps in the vessel wall to reach the tissue on the other side, just as they do in the human body.
AngioChip has great potential in the field of pharmaceutical testing. Current drug-testing methods, such as animal testing and controlled clinical trials, are costly and fraught with ethical concerns. Testing on lab-grown human tissues would provide a realistic model at a fraction of the cost, but this area of research is still in its infancy. “In the last few years, it has become possible to order cultures of human cells for testing, but they’re grown on a plate, a two-dimensional environment,” says Radisic. “They don’t capture all the functional hallmarks of a real heart muscle, for example.”
A more realistic platform like AngioChip could enable drug companies to detect dangerous side effects and interactions between organ compartments long before their products reach the market, saving countless lives. It could also be used to understand and validate the effectiveness of current drugs and even to screen libraries of chemical compounds to discover new drugs. Through TARA Biosystems Inc., a spin-off company co-founded by Radisic, the team is already working on commercializing the technology.
In future, Radisic envisions her lab-grown tissues being implanted into the body to repair organs damaged by disease. Because the cells used to seed the platform can come from anyone, the new tissues could be genetically identical to the intended host, reducing the risk of organ rejection. Even in its current form, the team has shown that the AngioChip can be implanted into a living animal, its artificial blood vessels connected to a real circulatory system. The polymer scaffolding itself simply biodegrades after several months.
The Latest on: Tissue engineering
via Google News
The Latest on: Tissue engineering
- Tissue Engineering Market 2021 : Latest Industry Trends, Growth, Share, Size and 2026 Forecast Research Report with Top countries Dataon April 5, 2021 at 5:33 pm
Global “Tissue Engineering Market" 2021-2026 Research Report provides key analysis on the market status of the ...
- Ultrashort peptides go a long way for tissue engineeringon April 5, 2021 at 7:27 am
A new automated process prints a peptide-based hydrogel scaffold containing uniformly distributed cells. The scaffolds hold their shapes well and successfully facilitate cell growth that lasts for ...
- Tissue Scaffolds Market to Grow by USD 1.20 Billion |Increasing Prevalence of Chronic and Acute Wounds to Drive Growth | Technavioon April 4, 2021 at 10:30 pm
Technavio forecast the global tissue scaffolds market is expected to grow by USD 1.20 billion during 2021-2025. This marks a significant ...
- This common shoulder injury could heal faster, thanks to the first implant that re-creates a crucial tissue structureon April 2, 2021 at 5:24 pm
But a shoulder injury such as a badly torn rotator cuff threatens to pause or end the career of any athlete in sports ranging from football, basketball and baseball to golf and tennis. Athletes ...
- Shape-shifting biomaterial could transform 4D tissue engineeringon April 1, 2021 at 2:40 am
New cell-friendly hydrogel morphs into vessel-like tubes on the timescales needed to promote tissue development and healing ...
- New tissue implant could benefit athletes sidelined with common shoulder injuryon March 31, 2021 at 4:57 pm
For sports fans, nothing beats seeing their favorite athletes compete at the top of their game. But a shoulder injury such as a badly torn rotator cuff threatens to pause or end the career of any ...
- A common shoulder injury could heal faster, thanks to this first-of-a-kind tissue implanton March 30, 2021 at 9:00 pm
A new implant on the market invented at Purdue University has the potential to significantly speed up a patient's recovery from rotator cuff surgery and offer a more robust repair that is less likely ...
- Tissue Engineering Market Research Analysis, Future Prospects and Growth Drivers to 2031| Stryker Corporation, Medtronic Inc, R. BARDon March 30, 2021 at 1:20 am
Pune, Maharashtra, India, March 30 2021 (Wiredrelease) MarketResearch.Biz –:The New Report “Tissue Engineering Market” posted through MarketResearch.Biz, covers the market panorama and its growth ...
- Biofabrication of chitosan/chitosan nanoparticles/polycaprolactone transparent membrane for corneal endothelial tissue engineeringon March 29, 2021 at 9:12 am
To the best of our knowledge, there is not much evidence for the use of nanoparticles in corneal endothelial tissue engineering. Nanoparticles are used in tissue engineering to mimic the natural ...
- Scaffold-free cell-based tissue engineering therapies: advances, shortfalls and forecaston March 29, 2021 at 4:04 am
Cell-based scaffold-free therapies seek to develop in vitro organotypic three-dimensional (3D) tissue-like surrogates, capitalising upon the inherent capacity of cells to create tissues with ...
via Bing News